tedopi
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 17, 2021 (NCT04884282)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07264673 | Phase 2 | Apr 17, 2025 | Fondazione Ricerca Traslazionale |
| NCT04884282 | Phase 2 | May 17, 2021 | Fondazione Ricerca Traslazionale |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Fondazione Ricerca Traslazionale | Academic/Hospital | 2 | 2 | 1 | 2021 |
1 organizations
Page 1 / 1